Watch the full video interview with Anders Månsson and Goran Dubravčić below.
”We show increasing sales but there is still a lot of untapped potential”, says new CEO of PHI
PHI specializes in non-invasive cell analysis, enabling researchers to study cells without disrupting their natural state. The company’s products and technology are utilized by customers worldwide. Recently, PHI welcomed Anders Månsson as its new CEO. In a video interview, Månsson and Chairman of the Board Goran Dubravčić discuss the company’s future strategy and the ongoing rights issue.
Notiser
BrainCool pausar stroke-studie
PHI får ny vd
AcouSort utökar europeiskt samarbete
Integrum stärker distribution i Ukraina
Active Biotech säkrar patent för tasquinimod
NYHETSBREV
NYHETER
Cereno Scientific går framåt på bred front under Q1
Cinclus Pharma skriver miljardavtal med Zentiva
Iconovo fokuserar på kommersialisering
Kommande event!
Investing in Life Science
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
Life Science Summit
The Nordic region’s leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
Du är värd det bästa!
Lås upp vårt premium-innehåll: Bli prenumerant!
Skapa konto
Krönikor
Första draget gjort – nu väntar vi på svar
Osäkerheten gör det svårare att deala
